US EditionFDA-Approved Blood Test for Alzheimer's Offers Hope for Early Intervention
8 Articles
8 Articles
(Seoul = Yonhap News) Reporter Kim Jan-di = A protein in the blood that can detect Alzheimer's disease, the most common degenerative brain disease that causes dementia, has been discovered.
5 things to know about new blood tests that diagnose Alzheimer's
vosgesmatin.fr
estrepublicain.frThe U.S. Drug Agency (FDA) has recently authorized the marketing of the first blood test to assist in the diagnosis of Alzheimer's disease.
Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species - Journal of Translational Medicine
The lack of a definitive cure for Alzheimer's disease (AD) is fueling the search for innovative therapeutic strategies. Having revolutionized cancer immunotherapy, immune cell engineering with chimeric antigen receptors (CAR) is being explored to target AD. Whether CARs can recognize distinct amyloid-β (Aβ) species and tau neurofibrillary tangles (NFTs)—hallmark pathologies of AD—remains unclear. To investigate this, we engineered a series of CA…
Early diagnosis makes a difference in Alzheimer's care - Waxahachie Daily Light
Staff report Early detection of Alzheimer’s and dementia can significantly improve outcomes for individuals and their families. During Alzheimer’s and Brain Awareness Month, the Texas… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium
